Wedbush Upgrades USANA (USNA) to Neutral on Stronger Asia and Recent Sell-Off

Go back to Wedbush Upgrades USANA (USNA) to Neutral on Stronger Asia and Recent Sell-Off

Usana Health Sciences, Inc. (USNA) Tops Q4 EPS by 6c

February 5, 2013 4:08 PM EST

Usana Health Sciences, Inc. (NYSE: USNA) reported Q4 EPS of $1.27, $0.06 better than the analyst estimate of $1.21. Revenue for the quarter came in at $168.5 million versus the consensus estimate of $165.8 million.

For earnings history and earnings-related data on Usana Health Sciences, Inc. (USNA) click here.... More